GlassScriptPhysician profile
Arun Krishnan
NPI 1790198265
$2,605.78
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $279 · 2021: $1,047 · 2022: $1,086.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $647.43 | 2021-2022 | |
| Allergan, INC. | $456.04 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $362.88 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $219.28 | 2021-2022 | |
| Alkermes, INC. | $189.06 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $186.23 | 2021-2022 | |
| Bausch Health US, LLC | $85.14 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $72.16 | 2021 | |
| Corium, LLC | $56.92 | 2022 | |
| Alfasigma USA, INC. | $56.40 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $53.06 | 2022 | |
| Neos Therapeutics, LP | $43.54 | 2021 | |
| Tris Pharma INC | $41.85 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.17 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $38.04 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $28.69 | 2021 | |
| Neuronetics, INC. | $16.06 | 2020 | |
| Lundbeck LLC | $13.83 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.